- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有6家主力机构披露2026-06-30报告期持股数据，持仓量总计4.67亿股，占流通A股81.74%
- 波段诊断：
-
技术面诊股
诊断结果：4.9技术面打败了45%的股票
技术面评分前10的股票
近期的平均成本为20.27元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为20.27元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.27","date":1787644606,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑赢大盘，明显跑输行业平均水平。
[{"date":"2026.08.26","stock":"0.90","trade":"0.81","ind":"0.69"},{"date":"2026.08.25","stock":"1.82","trade":"2.69","ind":"-0.35"},{"date":"2026.08.24","stock":"-0.65","trade":"-1.70","ind":"-2.13"},{"date":"2026.08.21","stock":"-3.92","trade":"-3.27","ind":"0.87"},{"date":"2026.08.20","stock":"2.99","trade":"2.42","ind":"0.59"},{"date":"2026.08.19","stock":"-1.33","trade":"-1.50","ind":"-5.01"},{"date":"2026.08.18","stock":"-1.07","trade":"-1.04","ind":"-0.56"},{"date":"2026.08.17","stock":"-0.10","trade":"0.49","ind":"2.44"},{"date":"2026.08.14","stock":"-1.44","trade":"-0.81","ind":"0.45"},{"date":"2026.08.13","stock":"1.36","trade":"1.59","ind":"-0.87"},{"date":"2026.08.12","stock":"-0.39","trade":"0.14","ind":"1.09"},{"date":"2026.08.11","stock":"-0.72","trade":"0.34","ind":"-0.40"},{"date":"2026.08.10","stock":"-0.71","trade":"0.39","ind":"0.04"},{"date":"2026.08.07","stock":"2.74","trade":"2.10","ind":"1.42"},{"date":"2026.08.06","stock":"-0.87","trade":"0.32","ind":"-0.24"},{"date":"2026.08.05","stock":"-1.25","trade":"-0.59","ind":"1.86"},{"date":"2026.08.04","stock":"-1.04","trade":"0.61","ind":"3.25"},{"date":"2026.08.03","stock":"0.48","trade":"0.76","ind":"-0.96"},{"date":"2026.07.31","stock":"0.38","trade":"1.71","ind":"2.21"},{"date":"2026.07.30","stock":"1.06","trade":"-0.93","ind":"-2.73"},{"date":"2026.07.29","stock":"2.07","trade":"0.54","ind":"1.10"}]
奇正藏药,深证成指,中药指数
压力支撑
该股压力位为20.17元，支撑位为19.90元。
[{"text":"\u538b\u529b\u4f4d","value":"20.17","date":1787673600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.90","date":1787673600,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了32%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：08月26日 16:56
| 机构今日流向(万元) | -1084.97 | 机构5日流向(万元) | -3966.46 |
| 机构10日流向(万元) | -10138.85 | 机构20日流向(万元) | -15383.85 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少444.24万股，其中基金净增仓2家，主力净减仓27家，暂未发现中长期投资价值。
截止2026-06-30，共6家主力机构（基金2家，QFII1家，一般法人3家），持仓量总计46671.51万股，占流通A股81.74%
其中，基金持仓与2025-12-31相比：
增仓：2家 ，增持 16.48万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有50.79万股
从主力名单中消失：28家 ，原持有343.75万股
其中，基金持仓与2025-12-31相比：
增仓：2家 ，增持 16.48万股
减仓：0家 ，减持 0万股
新出现在主力名单中：1家 ，持有50.79万股
从主力名单中消失：28家 ，原持有343.75万股
消息面诊股
诊断结果：6.5消息面打败了76%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 集采击穿利润空间， 中药板块站上“换季”拐点
2026-08-26 - 奇正藏药：8月25日获融资买入170.90万元
2026-08-26 - 奇正藏药发布2026年半年度报告 全产业链核心能力
2026-08-25 - 奇正藏药：8月24日获融资买入260.76万元
2026-08-25 - 奇正藏药持续夯实全产业链核心能力
2026-08-24 - 奇正藏药：8月21日获融资买入668.42万元
2026-08-24 - 股东追踪|高盛国际-自有资金新进奇正藏药前十大流通
2026-08-22 - 奇正藏药：公司将于8月26日召开2026年半年度报
2026-08-21 - 财报速递：奇正藏药2026年半年度净利润3.71亿
2026-08-24 - 奇正藏药半年度营业收入9.78亿元，同比下降16.
2026-08-21
消息列表
| 利好 | 分红转增 | 10派2.30元(含税) | 2026-08-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-08-14 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-07-01 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-13 |
| 一般消息 | 重大事项 | 关联交易 | 2026-06-06 |
| 一般消息 | 募资投向 | 2026-06-01 | |
| 利好 | 分红转增 | 10派4.1元(含税) | 2026-04-24 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-04-15 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-08 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-26 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-27 |
| 一般消息 | 高管变动 | 委员会调整 | 2025-10-27 |
| 一般消息 | 高管变动 | 因个人原因 | 2025-09-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.8行业面打败了88%的股票
中药行业最新资金流向
近10日来该行业走势不明显，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑赢大盘。
[{"date":"2026.08.26","price":"0.69","value":"0.81"},{"date":"2026.08.25","price":"-0.35","value":"2.69"},{"date":"2026.08.24","price":"-2.13","value":"-1.70"},{"date":"2026.08.21","price":"0.87","value":"-3.27"},{"date":"2026.08.20","price":"0.59","value":"2.42"},{"date":"2026.08.19","price":"-5.01","value":"-1.50"},{"date":"2026.08.18","price":"-0.56","value":"-1.04"},{"date":"2026.08.17","price":"2.44","value":"0.49"},{"date":"2026.08.14","price":"0.45","value":"-0.81"},{"date":"2026.08.13","price":"-0.87","value":"1.59"},{"date":"2026.08.12","price":"1.09","value":"0.14"},{"date":"2026.08.11","price":"-0.40","value":"0.34"},{"date":"2026.08.10","price":"0.04","value":"0.39"},{"date":"2026.08.07","price":"1.42","value":"2.10"},{"date":"2026.08.06","price":"-0.24","value":"0.32"},{"date":"2026.08.05","price":"1.86","value":"-0.59"},{"date":"2026.08.04","price":"3.25","value":"0.61"},{"date":"2026.08.03","price":"-0.96","value":"0.76"},{"date":"2026.07.31","price":"2.21","value":"1.71"},{"date":"2026.07.30","price":"-2.73","value":"-0.93"},{"date":"2026.07.29","price":"1.10","value":"0.54"}]
深证成指,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 汉森制药 | 89.44% | 55.46% | 5.5分 |
| 2 | 陇神戎发 | 29.75% | -6.80% | 5.4分 |
| 3 | 华森制药 | 28.47% | 0.31% | 6.2分 |
| 4 | 三力制药 | 22.89% | -0.79% | 5.1分 |
| 5 | 粤万年青 | 21.22% | -5.21% | 4.6分 |
| 6 | 维康药业 | 21.17% | -1.48% | 5.1分 |
| 8 | 太龙药业 | 16.11% | -1.23% | 4.9分 |
| 10 | 新天药业 | 13.76% | 3.09% | 5.7分 |
| 12 | 佛慈制药 | 11.54% | 5.13% | 6.3分 |
| 14 | 新光药业 | 10.62% | 3.16% | 5.4分 |
| 16 | 亚宝药业 | 9.97% | 2.58% | 6.7分 |
| 18 | 盘龙药业 | 9.35% | 0.94% | 5.5分 |
| 20 | 方盛制药 | 9.00% | 0.30% | 5.8分 |
| 22 | 益盛药业 | 7.20% | 2.49% | 5.6分 |
| 24 | *ST香雪 | 7.03% | -3.32% | 4.3分 |
| 26 | 振东制药 | 5.22% | -3.50% | 4.9分 |
| 28 | 精华制药 | 4.90% | 0.57% | 5.6分 |
| 30 | 信邦制药 | 4.38% | 1.97% | 5.3分 |
| 32 | 康恩贝 | 2.30% | 2.07% | 5.1分 |
| 34 | 特一药业 | 1.49% | -4.62% | 5.4分 |
| 36 | 红日药业 | 1.18% | 0.59% | 5.1分 |
| 38 | 仁和药业 | 0.91% | 1.66% | 5.9分 |
| 40 | ST百灵 | 0.44% | 2.91% | 5.5分 |
| 42 | 佐力药业 | 0.21% | -1.11% | 5.5分 |
| 44 | 健民集团 | -0.43% | -2.33% | 5.1分 |
| 46 | 奇正藏药 | -1.98% | 1.00% | 5.4分 |
| 48 | 天目药业 | -2.32% | -2.46% | 5.4分 |
| 50 | 葵花药业 | -3.64% | -0.30% | 5.4分 |
| 52 | 达仁堂 | -3.99% | 2.61% | 6.0分 |
| 54 | 以岭药业 | -4.07% | -2.85% | 5.5分 |
| 56 | 片仔癀 | -5.50% | 0.08% | 4.6分 |
| 58 | 众生药业 | -5.99% | -9.59% | 5.3分 |
| 60 | 广誉远 | -6.15% | 1.40% | 5.2分 |
| 62 | 济川药业 | -7.02% | 0.76% | 5.6分 |
| 64 | 太极集团 | -7.98% | -6.43% | 4.9分 |
| 66 | 华润江中 | -10.41% | -2.04% | 5.9分 |
| 68 | 羚锐制药 | -14.87% | -1.40% | 5.3分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 9/108 ， 1/108。
[{"date":"2026-06-30","value":"7.39","vol":"3.91"},{"date":"2026-03-31","value":"1.91","vol":"2.21"},{"date":"2025-12-31","value":"14.39","vol":"-2.33"},{"date":"2025-09-30","value":"9.55","vol":"4.80"},{"date":"2025-06-30","value":"8.85","vol":"4.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
7.39 | 1.91 | 14.39 | 9.55 | 8.85 |
| 行业(%) | 3.91 | 2.21 | -2.33 | 4.80 | 4.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"82.08","vol":"57.40"},{"date":"2026-03-31","value":"83.93","vol":"55.05"},{"date":"2025-12-31","value":"83.05","vol":"52.85"},{"date":"2025-09-30","value":"82.25","vol":"53.29"},{"date":"2025-06-30","value":"82.19","vol":"53.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
82.08 | 83.93 | 83.05 | 82.25 | 82.19 |
| 行业(%) | 57.40 | 55.05 | 52.85 | 53.29 | 53.82 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 30/108 ， 17/108。
[{"date":"2026-06-30","value":"-16.77","vol":"-8.50"},{"date":"2026-03-31","value":"0.56","vol":"-5.58"},{"date":"2025-12-31","value":"3.34","vol":"-6.76"},{"date":"2025-09-30","value":"3.48","vol":"-7.84"},{"date":"2025-06-30","value":"16.36","vol":"-7.78"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-16.77 | 0.56 | 3.34 | 3.48 | 16.36 |
| 行业(%) | -8.50 | -5.58 | -6.76 | -7.84 | -7.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"3.60","vol":"-47.18"},{"date":"2026-03-31","value":"25.77","vol":"1.06"},{"date":"2025-12-31","value":"11.36","vol":"-80.25"},{"date":"2025-09-30","value":"7.66","vol":"-2.78"},{"date":"2025-06-30","value":"10.04","vol":"2.25"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
3.60 | 25.77 | 11.36 | 7.66 | 10.04 |
| 行业(%) | -47.18 | 1.06 | -80.25 | -2.78 | 2.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 35/108 ， 32/108。
[{"date":"2026-06-30","value":"0.14","vol":"0.24"},{"date":"2026-03-31","value":"0.06","vol":"0.12"},{"date":"2025-12-31","value":"0.35","vol":"0.47"},{"date":"2025-09-30","value":"0.23","vol":"0.35"},{"date":"2025-06-30","value":"0.17","vol":"0.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.14 | 0.06 | 0.35 | 0.23 | 0.17 |
| 行业(次) | 0.24 | 0.12 | 0.47 | 0.35 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.56","vol":"1.19"},{"date":"2026-03-31","value":"0.21","vol":"0.59"},{"date":"2025-12-31","value":"1.71","vol":"2.34"},{"date":"2025-09-30","value":"1.16","vol":"1.72"},{"date":"2025-06-30","value":"1.07","vol":"1.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.56 | 0.21 | 1.71 | 1.16 | 1.07 |
| 行业(次) | 1.19 | 0.59 | 2.34 | 1.72 | 1.17 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/108 ， 31/108。
[{"date":"2026-06-30","value":"70.36","vol":"21.81"},{"date":"2026-03-31","value":"-40.34","vol":"5.83"},{"date":"2025-12-31","value":"25.44","vol":"30.77"},{"date":"2025-09-30","value":"3.25","vol":"10.53"},{"date":"2025-06-30","value":"30.49","vol":"22.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 70.36 | -40.34 | 25.44 | 3.25 | 30.49 |
| 行业 | 21.81 | 5.83 | 30.77 | 10.53 | 22.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.97","vol":"0.75"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.07","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.89","vol":"1.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.97 | - | 1.07 | - | 0.89 |
| 行业 | 0.75 | 0.00 | 1.00 | 0.00 | 1.03 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 21/108 ， 27/108。
[{"date":"2026-06-30","value":"2.99","vol":"3.53"},{"date":"2026-03-31","value":"3.12","vol":"2.97"},{"date":"2025-12-31","value":"2.57","vol":"2.94"},{"date":"2025-09-30","value":"2.63","vol":"3.09"},{"date":"2025-06-30","value":"2.53","vol":"2.94"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.99 | 3.12 | 2.57 | 2.63 | 2.53 |
| 行业 | 3.53 | 2.97 | 2.94 | 3.09 | 2.94 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"2.63","vol":"2.66"},{"date":"2026-03-31","value":"2.71","vol":"2.23"},{"date":"2025-12-31","value":"2.30","vol":"2.15"},{"date":"2025-09-30","value":"2.39","vol":"2.24"},{"date":"2025-06-30","value":"2.36","vol":"2.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
2.63 | 2.71 | 2.30 | 2.39 | 2.36 |
| 行业 | 2.66 | 2.23 | 2.15 | 2.24 | 2.15 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 24/108 ， 24/108。
[{"date":"2026-06-30","value":"23.55","vol":"30.23"},{"date":"2026-03-31","value":"23.56","vol":"31.94"},{"date":"2025-12-31","value":"27.77","vol":"32.43"},{"date":"2025-09-30","value":"26.92","vol":"31.59"},{"date":"2025-06-30","value":"40.16","vol":"32.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
23.55 | 23.56 | 27.77 | 26.92 | 40.16 |
| 行业(%) | 30.23 | 31.94 | 32.43 | 31.59 | 32.45 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.31","vol":"0.49"},{"date":"2026-03-31","value":"0.31","vol":"0.66"},{"date":"2025-12-31","value":"0.39","vol":"0.67"},{"date":"2025-09-30","value":"0.37","vol":"0.76"},{"date":"2025-06-30","value":"0.68","vol":"0.75"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.31 | 0.31 | 0.39 | 0.37 | 0.68 |
| 行业(%) | 0.49 | 0.66 | 0.67 | 0.76 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"4.72","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"5.81","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"5.82","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"6.48","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]